t7 rna polymerase Search Results


99
New England Biolabs t7 rna polymerase
T7 Rna Polymerase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/T7+RNA+Polymerase/us11624702-387-17-20
Average 99 stars, based on 1 article reviews
t7 rna polymerase - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

sp6  (TaKaRa)
96
TaKaRa sp6
Sp6, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/T7+RNA+Polymerase/pm19219059-52-12-17
Average 96 stars, based on 1 article reviews
sp6 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

92
Addgene inc pcdna3 1 þ vector
Pcdna3 1 þ Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/pcDNA3%2E1(%2B)+-+Hyperactive+AID+-+T7+RNA+Polymerase+-UGI+-+T2A+-+tdTamato+(Plasmid+%23138610)/10__1158_slash_1541___7786__mcr___22___0781-118-38-41
Average 92 stars, based on 1 article reviews
pcdna3 1 þ vector - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
TaKaRa t7 rna polymerase ver 2 0
(a) Optimization of elongation factor P (EF-P) and chaperone conditions. (b) Optimization of the linker length between Sso7d and SP6 RNA <t>polymerase.</t> (c) Crystal structure of T7 RNA polymerase initiation state (PDB ID: 2PI4). (d) Crystal structure of T7 RNA polymerase intermediate state (PDB ID: 3E2E). (e) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). (f) Predicted structure of SP6 RNA polymerase by ColabFold. N-terminal domains of RNA polymerases (Residues 1-240 in SP6 <t>RNAP,</t> residues 1-266 in T7 RNAP) are colored in purple, other regions are colored in gray. RNAs are colored in yellow and template DNAs are colored light purple, and non-templated DNAs are in pink.
T7 Rna Polymerase Ver 2 0, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/T7+RNA+Polymerase+ver%2E2%2E0/bio_rxiv__64898__2026__02__23__707346-219-33-38
Average 94 stars, based on 1 article reviews
t7 rna polymerase ver 2 0 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
New England Biolabs vitro transcription
(a) Optimization of elongation factor P (EF-P) and chaperone conditions. (b) Optimization of the linker length between Sso7d and SP6 RNA <t>polymerase.</t> (c) Crystal structure of T7 RNA polymerase initiation state (PDB ID: 2PI4). (d) Crystal structure of T7 RNA polymerase intermediate state (PDB ID: 3E2E). (e) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). (f) Predicted structure of SP6 RNA polymerase by ColabFold. N-terminal domains of RNA polymerases (Residues 1-240 in SP6 <t>RNAP,</t> residues 1-266 in T7 RNAP) are colored in purple, other regions are colored in gray. RNAs are colored in yellow and template DNAs are colored light purple, and non-templated DNAs are in pink.
Vitro Transcription, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/Hi-T7+RNA+Polymerase/bio_rxiv__64898__2026__05__08__723843-174-10-16
Average 95 stars, based on 1 article reviews
vitro transcription - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Jena Bioscience t7 rna polymerase mix
(a) Optimization of elongation factor P (EF-P) and chaperone conditions. (b) Optimization of the linker length between Sso7d and SP6 RNA <t>polymerase.</t> (c) Crystal structure of T7 RNA polymerase initiation state (PDB ID: 2PI4). (d) Crystal structure of T7 RNA polymerase intermediate state (PDB ID: 3E2E). (e) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). (f) Predicted structure of SP6 RNA polymerase by ColabFold. N-terminal domains of RNA polymerases (Residues 1-240 in SP6 <t>RNAP,</t> residues 1-266 in T7 RNAP) are colored in purple, other regions are colored in gray. RNAs are colored in yellow and template DNAs are colored light purple, and non-templated DNAs are in pink.
T7 Rna Polymerase Mix, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/T7+RNA+Polymerase/pmc11147952-257-12-23
Average 95 stars, based on 1 article reviews
t7 rna polymerase mix - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Vazyme Biotech Co t7 rna polymerase
(a) Optimization of elongation factor P (EF-P) and chaperone conditions. (b) Optimization of the linker length between Sso7d and SP6 RNA <t>polymerase.</t> (c) Crystal structure of T7 RNA polymerase initiation state (PDB ID: 2PI4). (d) Crystal structure of T7 RNA polymerase intermediate state (PDB ID: 3E2E). (e) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). (f) Predicted structure of SP6 RNA polymerase by ColabFold. N-terminal domains of RNA polymerases (Residues 1-240 in SP6 <t>RNAP,</t> residues 1-266 in T7 RNAP) are colored in purple, other regions are colored in gray. RNAs are colored in yellow and template DNAs are colored light purple, and non-templated DNAs are in pink.
T7 Rna Polymerase, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/T7+RNA+Polymerase/pm41999294-119-87-92
Average 95 stars, based on 1 article reviews
t7 rna polymerase - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Hzymes Biotechnology Co Ltd t7 rna polymerase
(a) Optimization of elongation factor P (EF-P) and chaperone conditions. (b) Optimization of the linker length between Sso7d and SP6 RNA <t>polymerase.</t> (c) Crystal structure of T7 RNA polymerase initiation state (PDB ID: 2PI4). (d) Crystal structure of T7 RNA polymerase intermediate state (PDB ID: 3E2E). (e) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). (f) Predicted structure of SP6 RNA polymerase by ColabFold. N-terminal domains of RNA polymerases (Residues 1-240 in SP6 <t>RNAP,</t> residues 1-266 in T7 RNAP) are colored in purple, other regions are colored in gray. RNAs are colored in yellow and template DNAs are colored light purple, and non-templated DNAs are in pink.
T7 Rna Polymerase, supplied by Hzymes Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/T7+RNA+Polymerase/pm40035925-132-0-3
Average 93 stars, based on 1 article reviews
t7 rna polymerase - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
TaKaRa primecap t7 rna polymerase kit
A , Schematic of IVT mRNA construct design. The template contains optimized 5’ and 3’ UTRs flanking a coding sequence, followed by a 50-adenosine poly(A) tail. Linearized templates are generated by PCR using a forward primer annealing to the <t>T7</t> promoter and a reverse primer containing two 2’-O-methylated ribonucleotides at the 5’ end to minimize dsRNA byproducts. In vitro transcription is performed with mutant T7 <t>polymerase</t> in the presence of CleanCap M6 for co-transcriptional capping along with different NTPs. B , Summary of mRNA constructs tested. Nine variants were generated incorporating different combinations of 5’ cap status (uncapped or CleanCap M6) and base modifications: unmodified (constructs 1, 2 ), N1-methylpseudouridine (m1Ψ; constructs 3, 4 ), 5-methylcytidine (m5C; constructs 5, 6 ), m1Ψ + m5C (construct 7 ), or 5-methoxyuridine (5moU; constructs 8, 9 ). C, Agarose gel electrophoresis of purified IVT mRNAs encoding nuclear mScarlet3 showing high yield and purity for all nine constructs. D, Schematic illustrating IVT mRNA transfection. IVT mRNAs were complexed with lipofectamine to form lipid nanoparticles, which were then delivered into cells to enable transient protein expression. E, Immunoblot images of stress response markers in U-2 OS cells 24 hours post-transfection. Lanes correspond to non-transfected control ( 0 ) and constructs 1-9 . No induction of phosphorylated eIF2α (p-eIF2α), RIG-I, or phosphorylated IRF3 (p-IRF3) was detected across conditions, indicating absence of dsRNA-triggered stress responses. Total IRF3, eIF2α, and tubulin serve as loading controls.
Primecap T7 Rna Polymerase Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/PrimeCap+T7+RNA+Polymerase/bio_rxiv__64898__2026__01__02__697412-291-10-9
Average 94 stars, based on 1 article reviews
primecap t7 rna polymerase kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Jena Bioscience t7 p l rna polymerase hc
In vitro transcription (IVT) reaction parameters and evaluation metric (see also Figure <xref ref-type= 1c )" width="250" height="auto" />
T7 P L Rna Polymerase Hc, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/T7+P%26L+RNA+Polymerase+HC/pmc09539360-90-5-10
Average 90 stars, based on 1 article reviews
t7 p l rna polymerase hc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
MedChemExpress t7 rna polymerase
In vitro transcription (IVT) reaction parameters and evaluation metric (see also Figure <xref ref-type= 1c )" width="250" height="auto" />
T7 Rna Polymerase, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7+rna+polymerase/T7+RNA+polymerase/pm33940159-269-17-38
Average 93 stars, based on 1 article reviews
t7 rna polymerase - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


(a) Optimization of elongation factor P (EF-P) and chaperone conditions. (b) Optimization of the linker length between Sso7d and SP6 RNA polymerase. (c) Crystal structure of T7 RNA polymerase initiation state (PDB ID: 2PI4). (d) Crystal structure of T7 RNA polymerase intermediate state (PDB ID: 3E2E). (e) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). (f) Predicted structure of SP6 RNA polymerase by ColabFold. N-terminal domains of RNA polymerases (Residues 1-240 in SP6 RNAP, residues 1-266 in T7 RNAP) are colored in purple, other regions are colored in gray. RNAs are colored in yellow and template DNAs are colored light purple, and non-templated DNAs are in pink.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) Optimization of elongation factor P (EF-P) and chaperone conditions. (b) Optimization of the linker length between Sso7d and SP6 RNA polymerase. (c) Crystal structure of T7 RNA polymerase initiation state (PDB ID: 2PI4). (d) Crystal structure of T7 RNA polymerase intermediate state (PDB ID: 3E2E). (e) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). (f) Predicted structure of SP6 RNA polymerase by ColabFold. N-terminal domains of RNA polymerases (Residues 1-240 in SP6 RNAP, residues 1-266 in T7 RNAP) are colored in purple, other regions are colored in gray. RNAs are colored in yellow and template DNAs are colored light purple, and non-templated DNAs are in pink.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques:

(a) Histograms of the fluorescence signal distribution of droplets screened for SP6 RNA polymerase in fluorescence-activated droplet sorting (FADS). The overlaid histogram is the same as . (b) Sequence alignment of evolved variants identified from Library 1-3. Residue numbers correspond to SP6 RNAP-wt (UniProt: P06221). The same residues relative to SP6 RNAP-wt are shown in dots. (c) Fluorescence of mNeonGreen expressed by Sso7d-SP6 RNAP variants identified from Library 1.3 in boosted PURE system. The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) Histograms of the fluorescence signal distribution of droplets screened for SP6 RNA polymerase in fluorescence-activated droplet sorting (FADS). The overlaid histogram is the same as . (b) Sequence alignment of evolved variants identified from Library 1-3. Residue numbers correspond to SP6 RNAP-wt (UniProt: P06221). The same residues relative to SP6 RNAP-wt are shown in dots. (c) Fluorescence of mNeonGreen expressed by Sso7d-SP6 RNAP variants identified from Library 1.3 in boosted PURE system. The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Fluorescence, Sequencing, Residue

(a-b) Histograms of the fluorescence signal distribution of droplets screened for SP6 RNA polymerase Library 2 or 3 in FADS. Overlaid histograms are the same as those in . (c) Sequence alignment of evolved variants identified from Library 3.3. Residue numbers correspond to SP6 RNAP-wt (UniProt: P06221). The same residues relative to SP6 RNAP-wt are shown in dots.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a-b) Histograms of the fluorescence signal distribution of droplets screened for SP6 RNA polymerase Library 2 or 3 in FADS. Overlaid histograms are the same as those in . (c) Sequence alignment of evolved variants identified from Library 3.3. Residue numbers correspond to SP6 RNAP-wt (UniProt: P06221). The same residues relative to SP6 RNAP-wt are shown in dots.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Fluorescence, Sequencing, Residue

(a) The activity measurement of SP6 RNAP variants identified from Library 3.3 by mNG reporter assay in boosted PURE system. (b) The activity measurement of SP6 RNAP variants with or without Sso7d by mNG reporter assay in boosted PURE system. (c) Sequence alignment of evolved variants identified from Library 3.3. Residue numbers correspond to SP6 RNAP-wt (UniProt: P06221). The same residues relative to SP6 RNAP-wt are shown in dots. The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) The activity measurement of SP6 RNAP variants identified from Library 3.3 by mNG reporter assay in boosted PURE system. (b) The activity measurement of SP6 RNAP variants with or without Sso7d by mNG reporter assay in boosted PURE system. (c) Sequence alignment of evolved variants identified from Library 3.3. Residue numbers correspond to SP6 RNAP-wt (UniProt: P06221). The same residues relative to SP6 RNAP-wt are shown in dots. The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Activity Assay, Reporter Assay, Sequencing, Residue

(a) Mapping the mutations of SP6 RNAP-v3 onto the predicted structure of SP6 RNAP-wt (shown in light green spheres). The N-terminal domain where random mutations were introduced in the library preparation is colored purple. (b, c) The real-time fluorescence values of mNeonGreen (mNG) in the PURE system at 37 °C ( b ) or Wheat Germ system at 25 °C ( c ). DNA encoding mNG under SP6 promoter (2 nM, 200 pM, 20 pM or 2 pM) and purified SP6 RNAPs were mixed with PURE system and fluorescence values were monitored in a real-time PCR system. The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) Mapping the mutations of SP6 RNAP-v3 onto the predicted structure of SP6 RNAP-wt (shown in light green spheres). The N-terminal domain where random mutations were introduced in the library preparation is colored purple. (b, c) The real-time fluorescence values of mNeonGreen (mNG) in the PURE system at 37 °C ( b ) or Wheat Germ system at 25 °C ( c ). DNA encoding mNG under SP6 promoter (2 nM, 200 pM, 20 pM or 2 pM) and purified SP6 RNAPs were mixed with PURE system and fluorescence values were monitored in a real-time PCR system. The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Fluorescence, Purification, Real-time Polymerase Chain Reaction

RNA products transcribed in vitro by SP6 RNAP-wt ( a ) or SP6 RNAP-v3 ( b ) in different buffer conditions were analyzed by denaturing PAGE. Band intensities of desired RNAs, indicated by black arrows, were quantified and normalized to that of RNA produced by SP6 RNAP-wt in typical transcription buffer. The conditions mimicking the PURE system are colored red.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: RNA products transcribed in vitro by SP6 RNAP-wt ( a ) or SP6 RNAP-v3 ( b ) in different buffer conditions were analyzed by denaturing PAGE. Band intensities of desired RNAs, indicated by black arrows, were quantified and normalized to that of RNA produced by SP6 RNAP-wt in typical transcription buffer. The conditions mimicking the PURE system are colored red.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: In Vitro, Produced

(a) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). Split site of previously reported spT7 RNAP is between K179 (red sphere) and K180 (blue sphere). Protein is colored in green, RNAs are colored orange, template DNAs are colored light purple, and non-templated DNAs are in pink. (b) Predicted structure of SP6 RNA polymerase by ColabFold. Split sites tried in this study are shown in red and blue spheres. (c) Rapamycin-induced spSP6 RNAP activities measured by mNG reporter assay in PURE system. The data are presented as the mean ± SD from three independent experiments. (d, e) Histograms of the fluorescence signal distribution of droplets screened for spSP6 RNAP Library 4 ( d ) or Library 5 ( e ) in FADS. Overlaid histograms are the same as or 3c. (f, g) Sequence alignment of evolved variants identified from Library 4.3 ( f ) and Library 5.3 ( g ). Residue numbers correspond to SP6 RNAP-wt (UniProt: P06221). The same residues relative to SP6 RNAP-v3 are shown in dots. ( h, i ) Rapamycin-induced spSP6 RNAPs’ activity measured by mNG reporter assay in PURE system. The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) Crystal structure of T7 RNA polymerase elongation state (PDB ID: 1H38). Split site of previously reported spT7 RNAP is between K179 (red sphere) and K180 (blue sphere). Protein is colored in green, RNAs are colored orange, template DNAs are colored light purple, and non-templated DNAs are in pink. (b) Predicted structure of SP6 RNA polymerase by ColabFold. Split sites tried in this study are shown in red and blue spheres. (c) Rapamycin-induced spSP6 RNAP activities measured by mNG reporter assay in PURE system. The data are presented as the mean ± SD from three independent experiments. (d, e) Histograms of the fluorescence signal distribution of droplets screened for spSP6 RNAP Library 4 ( d ) or Library 5 ( e ) in FADS. Overlaid histograms are the same as or 3c. (f, g) Sequence alignment of evolved variants identified from Library 4.3 ( f ) and Library 5.3 ( g ). Residue numbers correspond to SP6 RNAP-wt (UniProt: P06221). The same residues relative to SP6 RNAP-v3 are shown in dots. ( h, i ) Rapamycin-induced spSP6 RNAPs’ activity measured by mNG reporter assay in PURE system. The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Reporter Assay, Fluorescence, Sequencing, Residue, Activity Assay

(a) Schematic illustration of measuring the rapamycin-dependent activity of spSP6 RNA polymerases expressed by cell-free translation system from single-copy DNA in water-in-oil emulsion. (b-c) Histograms of the fluorescence signal distribution of droplets screened for Rapa-spSP6 RNA polymerase activity in fluorescence-activated droplet sorting (FADS). In each round of directed evolution, sorting was repeated three times. The histograms corresponding to each sorting are colored in green (1st), orange (2nd), pink (3rd). The directed evolution using Library 4 is shown in ( b ) and Library 5 is in ( c ). The individual histograms are shown in Extended Data Fig. 6. (d) Mapping the mutations of spSP6 RNAP-v4 onto the predicted structure of SP6 RNAP-wt. The N-terminal fragment of spSP6 RNAP is colored red and the region where random mutations were introduced in the C-terminal fragments is colored blue. The mutations from SP6 RNAP-v3 to spSP6 RNAP-v4 are shown in orange spheres. Light green spheres indicate the mutations in SP6 RNAP-v3 from SP6 RNAP-wt. (e) Endpoint measurement of rapamycin-induced mNG expression by spSP6 RNAPs in the PURE system. (f) Time course measurement of mNG fluorescence values in the PURE system by split RNAPs. The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) Schematic illustration of measuring the rapamycin-dependent activity of spSP6 RNA polymerases expressed by cell-free translation system from single-copy DNA in water-in-oil emulsion. (b-c) Histograms of the fluorescence signal distribution of droplets screened for Rapa-spSP6 RNA polymerase activity in fluorescence-activated droplet sorting (FADS). In each round of directed evolution, sorting was repeated three times. The histograms corresponding to each sorting are colored in green (1st), orange (2nd), pink (3rd). The directed evolution using Library 4 is shown in ( b ) and Library 5 is in ( c ). The individual histograms are shown in Extended Data Fig. 6. (d) Mapping the mutations of spSP6 RNAP-v4 onto the predicted structure of SP6 RNAP-wt. The N-terminal fragment of spSP6 RNAP is colored red and the region where random mutations were introduced in the C-terminal fragments is colored blue. The mutations from SP6 RNAP-v3 to spSP6 RNAP-v4 are shown in orange spheres. Light green spheres indicate the mutations in SP6 RNAP-v3 from SP6 RNAP-wt. (e) Endpoint measurement of rapamycin-induced mNG expression by spSP6 RNAPs in the PURE system. (f) Time course measurement of mNG fluorescence values in the PURE system by split RNAPs. The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Activity Assay, Emulsion, Fluorescence, Expressing

(a) Schematic illustration of orthogonality between spCGG RNAP and spSP6 RNAP measured by mNG reporter assay in PURE system. (b) Rapamycin-induced split RNAPs activity measured by mNG reporter assay in PURE system. The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) Schematic illustration of orthogonality between spCGG RNAP and spSP6 RNAP measured by mNG reporter assay in PURE system. (b) Rapamycin-induced split RNAPs activity measured by mNG reporter assay in PURE system. The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Reporter Assay, Activity Assay

Each protein is encoded on linear DNA under the T7 promoter. The interactions between molecules fused to the fragments of spSP6 RNAP-v4 activate RNAP. The expression level of reporter fluorescent protein under the SP6 promoter was monitored in a time-dependent manner. (a) Human Aurora A kinase (hAurA) or its negative mutant (Y199K) was fused to the N-terminal fragment of spSP6 RNAP-v4 as a target, and a peptide ligand (TPX2) was fused to the C-terminal fragment of spSP6 RNAP-v4 . (b) VH and VL domains of anti-HCV IRES RNA antibody were fused to the N- and C-terminal fragments of spSP6 RNAP-v4 . In vitro transcribed HCV IRES RNA at different concentrations was added as a target molecule. (c) Anti-eGFP nanobodies (LaG2 and LaG14) were fused to the N- and C-terminal fragments of spSP6 RNAP-v4 . Purified eGFP at different concentrations was added as a target molecule. (d) Human Brd4 bromodomain 2 (Brd4 BD ) and VHL were fused to the N- and C-terminal fragments of spSP6 RNAP-v4 . Elongin B and Elongin C proteins were co-expressed in the PURE system to stabilize VHL. PROTAC molecule MZ1 was added as a molecular glue at different conditions. (a-d) The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: Each protein is encoded on linear DNA under the T7 promoter. The interactions between molecules fused to the fragments of spSP6 RNAP-v4 activate RNAP. The expression level of reporter fluorescent protein under the SP6 promoter was monitored in a time-dependent manner. (a) Human Aurora A kinase (hAurA) or its negative mutant (Y199K) was fused to the N-terminal fragment of spSP6 RNAP-v4 as a target, and a peptide ligand (TPX2) was fused to the C-terminal fragment of spSP6 RNAP-v4 . (b) VH and VL domains of anti-HCV IRES RNA antibody were fused to the N- and C-terminal fragments of spSP6 RNAP-v4 . In vitro transcribed HCV IRES RNA at different concentrations was added as a target molecule. (c) Anti-eGFP nanobodies (LaG2 and LaG14) were fused to the N- and C-terminal fragments of spSP6 RNAP-v4 . Purified eGFP at different concentrations was added as a target molecule. (d) Human Brd4 bromodomain 2 (Brd4 BD ) and VHL were fused to the N- and C-terminal fragments of spSP6 RNAP-v4 . Elongin B and Elongin C proteins were co-expressed in the PURE system to stabilize VHL. PROTAC molecule MZ1 was added as a molecular glue at different conditions. (a-d) The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Expressing, Mutagenesis, In Vitro, Purification

The expression level of reporter fluorescent protein under the SP6 promoter was monitored in a time-dependent manner. (a, b) Human Aurora A kinase (hAurA) or its negative mutant (Y199K) was fused to the N-terminal fragment of spSP6 RNAP-v4 as a target, and monobody Mb1 ( a ) or Mb6 ( b ) was fused to the C-terminal fragments of spSP6 RNAP-v4. (c, d) Human VHL and Brd4 bromodomain 2 (Brd4 BD ) were fused to N- and C-terminal fragments of spSP6 RNAP-v4. In the presence of 4 μM MZ1 molecular glue, bromodomain binder (+)-JQ1 ( c ) or VHL binder VH032 ( d ) were added to inhibit the molecular glue activity of MZ1. The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: The expression level of reporter fluorescent protein under the SP6 promoter was monitored in a time-dependent manner. (a, b) Human Aurora A kinase (hAurA) or its negative mutant (Y199K) was fused to the N-terminal fragment of spSP6 RNAP-v4 as a target, and monobody Mb1 ( a ) or Mb6 ( b ) was fused to the C-terminal fragments of spSP6 RNAP-v4. (c, d) Human VHL and Brd4 bromodomain 2 (Brd4 BD ) were fused to N- and C-terminal fragments of spSP6 RNAP-v4. In the presence of 4 μM MZ1 molecular glue, bromodomain binder (+)-JQ1 ( c ) or VHL binder VH032 ( d ) were added to inhibit the molecular glue activity of MZ1. The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Expressing, Mutagenesis, Activity Assay

(a) Schematic illustration of RNAP activity measurement in E. coli . (b) Rapamycin-induced RNAP activities measured by mScarlet-I3 reporter assay in E. coli . The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) Schematic illustration of RNAP activity measurement in E. coli . (b) Rapamycin-induced RNAP activities measured by mScarlet-I3 reporter assay in E. coli . The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Activity Assay, Reporter Assay

(a) Schematic illustration of rapamycin-induced gene of interest (GOI) expression in mammalian cells. (b) Fluorescence microscopy images of HEK293 cells expressing eGFP (green) upon rapamycin treatment. Nuclei were stained with Hoechst 33342 (blue). Scale bars are 100 μm. (c-e) Rapamycin-induced NanoLuc expression in HEK293 cells. (f) NanoLuc expression in HEK293 cells transfected with pCMV-SP6 RNAP-wt-NanoLuc or pCMV-SP6 RNAP-v3-NanoLuc. Luminescence signal was normalized by the fluorescence intensity of cells stained with Hoechst 33342. The data are presented as the mean ± SD from three independent experiments.

Journal: bioRxiv

Article Title: Efficient cell-free evolution of RNA polymerases by droplet microfluidics

doi: 10.64898/2026.02.23.707346

Figure Lengend Snippet: (a) Schematic illustration of rapamycin-induced gene of interest (GOI) expression in mammalian cells. (b) Fluorescence microscopy images of HEK293 cells expressing eGFP (green) upon rapamycin treatment. Nuclei were stained with Hoechst 33342 (blue). Scale bars are 100 μm. (c-e) Rapamycin-induced NanoLuc expression in HEK293 cells. (f) NanoLuc expression in HEK293 cells transfected with pCMV-SP6 RNAP-wt-NanoLuc or pCMV-SP6 RNAP-v3-NanoLuc. Luminescence signal was normalized by the fluorescence intensity of cells stained with Hoechst 33342. The data are presented as the mean ± SD from three independent experiments.

Article Snippet: The b-PURE reaction mixture consisted of 50% Solution I, 5% Solution II, 2.5% Solution III, 10% RNasin Plus Ribonuclease inhibitor (N2615, Promega), 0.625% EF-P (PFS052, GeneFrontier), 1.25% DnaK mix (PF003, GeneFrontier) and 10% T7 RNA polymerase ver.2.0 (2541A, TaKaRa).

Techniques: Expressing, Fluorescence, Microscopy, Staining, Transfection

A , Schematic of IVT mRNA construct design. The template contains optimized 5’ and 3’ UTRs flanking a coding sequence, followed by a 50-adenosine poly(A) tail. Linearized templates are generated by PCR using a forward primer annealing to the T7 promoter and a reverse primer containing two 2’-O-methylated ribonucleotides at the 5’ end to minimize dsRNA byproducts. In vitro transcription is performed with mutant T7 polymerase in the presence of CleanCap M6 for co-transcriptional capping along with different NTPs. B , Summary of mRNA constructs tested. Nine variants were generated incorporating different combinations of 5’ cap status (uncapped or CleanCap M6) and base modifications: unmodified (constructs 1, 2 ), N1-methylpseudouridine (m1Ψ; constructs 3, 4 ), 5-methylcytidine (m5C; constructs 5, 6 ), m1Ψ + m5C (construct 7 ), or 5-methoxyuridine (5moU; constructs 8, 9 ). C, Agarose gel electrophoresis of purified IVT mRNAs encoding nuclear mScarlet3 showing high yield and purity for all nine constructs. D, Schematic illustrating IVT mRNA transfection. IVT mRNAs were complexed with lipofectamine to form lipid nanoparticles, which were then delivered into cells to enable transient protein expression. E, Immunoblot images of stress response markers in U-2 OS cells 24 hours post-transfection. Lanes correspond to non-transfected control ( 0 ) and constructs 1-9 . No induction of phosphorylated eIF2α (p-eIF2α), RIG-I, or phosphorylated IRF3 (p-IRF3) was detected across conditions, indicating absence of dsRNA-triggered stress responses. Total IRF3, eIF2α, and tubulin serve as loading controls.

Journal: bioRxiv

Article Title: mRNAbow : A versatile gene expression system for multiplexed fluorescent imaging using optimized in vitro transcribed mRNA

doi: 10.64898/2026.01.02.697412

Figure Lengend Snippet: A , Schematic of IVT mRNA construct design. The template contains optimized 5’ and 3’ UTRs flanking a coding sequence, followed by a 50-adenosine poly(A) tail. Linearized templates are generated by PCR using a forward primer annealing to the T7 promoter and a reverse primer containing two 2’-O-methylated ribonucleotides at the 5’ end to minimize dsRNA byproducts. In vitro transcription is performed with mutant T7 polymerase in the presence of CleanCap M6 for co-transcriptional capping along with different NTPs. B , Summary of mRNA constructs tested. Nine variants were generated incorporating different combinations of 5’ cap status (uncapped or CleanCap M6) and base modifications: unmodified (constructs 1, 2 ), N1-methylpseudouridine (m1Ψ; constructs 3, 4 ), 5-methylcytidine (m5C; constructs 5, 6 ), m1Ψ + m5C (construct 7 ), or 5-methoxyuridine (5moU; constructs 8, 9 ). C, Agarose gel electrophoresis of purified IVT mRNAs encoding nuclear mScarlet3 showing high yield and purity for all nine constructs. D, Schematic illustrating IVT mRNA transfection. IVT mRNAs were complexed with lipofectamine to form lipid nanoparticles, which were then delivered into cells to enable transient protein expression. E, Immunoblot images of stress response markers in U-2 OS cells 24 hours post-transfection. Lanes correspond to non-transfected control ( 0 ) and constructs 1-9 . No induction of phosphorylated eIF2α (p-eIF2α), RIG-I, or phosphorylated IRF3 (p-IRF3) was detected across conditions, indicating absence of dsRNA-triggered stress responses. Total IRF3, eIF2α, and tubulin serve as loading controls.

Article Snippet: In vitro transcription (IVT) was carried out using the Takara PrimeCap T7 RNA polymerase kit, which employs a mutated T7 RNA polymerase engineered to minimize double-stranded RNA (dsRNA) by-products, thereby improving transcript purity and translation efficiency.

Techniques: Construct, Sequencing, Generated, Methylation, In Vitro, Mutagenesis, Agarose Gel Electrophoresis, Purification, Transfection, Expressing, Western Blot, Control

In vitro transcription (IVT) reaction parameters and evaluation metric (see also Figure <xref ref-type= 1c )" width="100%" height="100%">

Journal: Biotechnology and Bioengineering

Article Title: Maximizing mRNA vaccine production with Bayesian optimization

doi: 10.1002/bit.28216

Figure Lengend Snippet: In vitro transcription (IVT) reaction parameters and evaluation metric (see also Figure 1c )

Article Snippet: IVT reactions are performed using T7 P&L RNA polymerase HC (Jena Biosciences).

Techniques: In Vitro

mRNA production reaction parameters and mRNA concentration for highest production conditions after Bayesian optimization (Reactions 1–6) compared to the benchmark reaction (Bancel et al., <xref ref-type= 2016 ) condition (Reaction 7)" width="100%" height="100%">

Journal: Biotechnology and Bioengineering

Article Title: Maximizing mRNA vaccine production with Bayesian optimization

doi: 10.1002/bit.28216

Figure Lengend Snippet: mRNA production reaction parameters and mRNA concentration for highest production conditions after Bayesian optimization (Reactions 1–6) compared to the benchmark reaction (Bancel et al., 2016 ) condition (Reaction 7)

Article Snippet: IVT reactions are performed using T7 P&L RNA polymerase HC (Jena Biosciences).

Techniques: Concentration Assay